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History 
Clinical enzymology was born in 1908 when 
Wohlgemuth discovered the increase in alpha-amylase 
activity in serum and urine in acute pancreatitis [ 1 ]. 
Apparently, the time was ripe: the coincidence with 
Garrod's concept of the 'inborn errors of metabolism' 
(1909) is conspicuous [2]. However, diagnostic 
enzymology developed only slowly, despite the 
discovery of the increase in lipase activity concomitant 
with amylase activity in serum during acute pan- 
creatitis by Rona in 1915 [3]. Other digestive 
enzymes were then proposed for diagnostic purposes, 
mainly in malignancies of the gastrointestinal tract, 
but they failed to meet he expectations of them. The 
next step occurred about 20 years later, when 
Robinson [4] and Kay [5] introduced the determina- 
tion of alkaline phosphatases in serum for the diag- 
nosis of bone and liver diseases. Again ten years later 
the clinical value of acid phosphatases in serum was 
first appreciated by the Gutman's in bone metastases 
from carcinoma of the prostate [6]. 
At that time the essential methods for the routine 
use of enzyme determinations i  the serum existed, 
namely, the introduction of photometers into clinical 
laboratories by Heilmeyer [7], and the invention of 
the optical test by Warburg [8]. Further slow progress 
may have been partially due to the environmental 
circumstances which impeded investigation and inter- 
rupted the communication between scientists of 
different countries. Otherwise it is hardly conceivable 
that the significance of Warburg's and Christian's 
discovery in 1943 [9] of the elevation of glycolytic 
enzymes in the serum of tumor-bearing animals would 
have needed five years and more before it dawned 
upon clinical medicine. The systematic work of 
Sibley and Lehninger [10], first published in 1949, 
extended the data published by Warburg and his 
co-workers and stimulated investigations in many 
places. 
The def'mitive break-through took place simultane- 
ously in the USA and in Italy with the publications 
on transaminases byKarmen, Wroblewski and La 
Due [11], and De Ritis and his co-workers [12], 
respectively. The obvious improvement in the 
diagnosis of myocardial infarction and acute viral 
hepatitis led to persistent endeavours in the investiga- 
tion of a wide variety of enzymes and their diagnostic 
value. These in turn resulted in an exponentially 
growing literature on the subject, which reached 
rather unmanageable proportions in the late sixties. 
Out of the bulk of enzymes then on trial, no more 
than a good dozen emerged as choice diagnostic aids. 
Some of the enzymes listed in table 1 are now 
measured in virtually all hospitals and in many medical 
offices throughout the world. With others, however, 
there are considerable r gional differences of usage: 
ICDH [13] for example, seems to be an enzyme of 
Anglo-Saxon interest, OCT [14] has hardly passed 
over the borders of the Scandinavian countries and 
GLDH [15] is virtually confined to laboratories in
Austria and Germany. 
On the whole, enzyme determinations i  serum 
have attained an assured place in clinical practice, 
and much empirical knowledge on their significance 
has accumulated. 
Pathophysiology 
In contrast to the practical significance of enzyme 
levels in the plasma, the present knowledge of how 
they come about is still relatively fragmentary. A 
given enzyme activity in the plasma can be considered 
as the result of the rates of inflow, distribution and 
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Table 1 
Name EC Number Abbreviation 
Acid phosphatase 3.1.3.2 SP 
Alanine aminotransferase 2.6.1.2 GPT 
Aldolase 4.1.2.13 ALD 
Alkaline phosphatase 3.1.3.1 AP 
a-Amylase 3.2.1.1 Amylase 
Aspartate aminotransferase 2.6.1.1 GOT 
Cholinesterase 3.1.1.8 CHE 
Creatine kinase 2.7.3.2 CPK 
Glutamate dehydrogenase (NAD(P) ÷) 1.4.1.3 GLDH 
"r-Glutamyl transferase 2.3.2.2 3,-GT 
Isocitrate dehydrogenase (NADP ÷) I. 1.1.42 ICDH 
Lactate dehydrogenase 1.1.1.27 LDH 
L-Leucin arylamidase 3.4.1.- LAP 
5-Nueleotidase 3.1.3.5 5-N 
Ornithin carbamoyltransferase 2.1.3,3 OCT 
Triacylglycerol lipase 3.1.1.3 Lipase 
outflow, as outlined in the simplified diagram on the 
fate of  cellular enzymes in the extracellular space 
(fig.l). 
The starting-point in this process is the concentra- 
tion of  cellular enzymes within their cells of origin, 
which vary to a considerable extent, according to the 
type of cells and their metabolic functions [16-18] .  
The cellular enzyme patterns, well known for the 
majority of tissues, are fairly constant in normal 
circumstances, though affected even physiologically 
by developmental, nutritional, hormonal and other 
factors [ 19,20]. Under pathological conditions, 
additional variations occur by disturbances and reac- 
tive changes in the intracellular protein turnover [21]. 
The enzyme pattern in the serum depends primarily 
on the concentration gradient between the intra- and 
extracellular space [22]. 
The concentration gradients of the enzymes 
Liver Cells 
Synthesis enhanced 
Degradation reduced 
Activity increased 
Normallp ) i f f lux~ 
Activity inhibited 
DegradatiOn enhanced 
Synthesis reduced 
ExtracelluiarS_~ 
Intravascular Space 
/ , 
Lymph 
Ve s se is 
k 
Interstitial Space 
~Bi le  ) Gut 
Tissues 
~--)Spleen 
Liver 
Endothelial 
Cells 
Blood Cells 
~-~ Other 
Tissues 
Q "Sofort-Effekt" 
Phase of Distribution 
Phase of Elimination 
Enzyme Degradation 
Fig. 1. Scheme of enzyme release, distribution and elimination. 
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between the cells and their environment are so steep 
that their maintenance r quires aconsiderable portion 
of the energy-yield of the cell. The complex structure 
of cellular membranes, serving the opposing functions 
of the preservation of cellular integrity on the one 
hand, and of the continuous orderly exchange of a 
variety of substances on the other, are therefore very 
vulnerable. It is well-known that the release of 
potassium and other low molecular weight cell 
constituents occurs at an early stage of cellular injury. 
It came as a surprise, however, that simultaneously 
high molecular weight cellular enzymes likewise begin 
to leak out. The first investigators of enzyme leakage, 
e.g. Warburg [23] or Zierler [24] showed this clearly 
by their experiments with cell suspensions and iso- 
lated muscle. 
Despite this evidence a tedious discussion lasted 
for years concerning whether enzyme levations in 
the serum must be considered as always being indica- 
tive of cellular necrosis. Just the contrary could be 
learned from clinical experience, .g. in acute hepatitis 
or in right heart failure. Moreover, one glance at the 
pathological enzyme patterns in the serum reveals 
that they very seldom reflect exactly the pattern of 
the afflicted tissue, but are distorted by various 
factors [22,25-29]. 
Some of these factors have been elucidated, mainly 
by studies on the isolated perfused liver. This model 
offers several advantages; the anatomical integrity of 
the organ is maintained, and many functional proper- 
ties are known to persist for an adequate time; and 
the experimental conditions can be controlled and 
varied without disturbance form the reactions of the 
whole body. The significance of the intraceUular 
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localisation of enzymes could be demonstrated: the 
leakage of mitochondrial enzymes and isoenzymes i  
delayed and is much less than that of the cytosolic 
ones [26,30-33]. It ceases again with about one 
third of these enzymes still in place, when the dis- 
integration of the dead cells begins, whereas the 
efflux of cytosolic enzymes goes on up to equilibrium 
with the environment [34]. Comparison with mor- 
phology shows that the release of these mitochondrial 
proteins is in fact a sympton of necrobiosis. Thus the 
relation of cytosolic and mitochondrial enzymes in 
the serum can be used diagnostically for the estimation 
of the severity of single cell damage, independent of
the absolute nzyme levels which are a measure of 
the number of ceils involved and thus of the size of 
the damaged area of tissue [22,35]. The molecular 
weight, which also affects the release rate of enzymes, 
is of minor diagnostic importance; only insofar as for 
a given pathological state the release rate of small 
enzymes i higher than that of the large molecules. 
So the former are more sensitive indicators of cellular 
injury in general than the latter [30]. The various 
causes of the 'leakiness' of the cells result in three 
major deficiencies: 
(1) Disproportion between requirement and supply 
of oxygen. 
(2) Disproportion between requiremen t and supply 
of metabolizable substrates. 
(3) Incapability of the cell to meet its requirements 
of energy by utilizing the supply of oxygen and 
substrates. 
Fig.2 demonstrates how relative low oxygenation due 
to an increased requirement with elevation of tempe- 
rature leads to an augmented release of enzymes from 
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Table 2 
Effect of the nutritionel state on the isolated rat liver 
after 4 hours of hemoglobin-free p rfusion at 23°C 
Fed rats Fasted rats 
(n = 10) (n = 6) 
Glycogen (mg/gliver) 44.7 ± 2.7 0.41 ± 0.18 
Lactate/pyruvate (liver) 4.2 ± 0.8 4.3 ± 0.5 
ATP/ADP (liver) 4.06 ± 1.09 4.03 ± 1.15 
Oxygen consumption 
(~umol/min × 100 g liver) 0.84 +- 0.23 0.89 ± 0.27 
Glucose (perfusion medium) 
(mmol/l) 6.6 -+ 0.6 5.9 ± 0.28 
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the perfused liver. This occurs immediately with 
mitochondrial (and acinocentral) GLDH, later with 
partly mitochondrial GOT, and even more delayed 
with cytosolic GPT and LDH. Though oxygen con- 
sumption is twice as high at 37°C as it is at 23°C, the 
relative oxygen shortage can clearly be read from the 
continually increasing lactate/pyruvate ratio [36]. 
Fig.3 shows that temporary absolute lack of oxygen 
also leads to a steep rise in enzyme activities in the 
perfusion medium, which persists (with the exception 
of GLDH) after the restitution of oxygen supply. 
The significance of the nutritional state of the cells 
is shown in fig.4. The release rates from the livers of 
fasted rats are between 2.5-fold and 5-fold higher than 
from fed rats, though oxygen consumption is similar 
in both conditions, and extracellular glucose levels are 
very well maintained by the glycogen-depleted livers. 
The same is true for the lactate/pyruvate and the 
ATP/ADP ratios in the liver [36] (table 2). The 
histological appearance of the liver tissue is likewise 
virtually normal. These results among many others 
show that the release of cellular enzymes i one of the 
most sensitive parameters for the recognition of 
minute disturbances of cellular integrity. 
When increased permeability has been produced 
previously by a variety of causes, enzyme leakage 
from the perfused liver was considerably aggravated 
(fig.5) [36]. In comparing the different types of 
injury not only quantitative variations can be noticed, 
but there are also conspicuous qualitative differences 
of the enzyme patterns in the perfusion medium. 
These can be attributed on the one hand to different 
involvement of subcellular structures with the differ- 
ent toxic substances, thus proving again the impor- 
tance of the intracellular localization of enzymes 
(fig.6) [36]. On the other hand, the heterogeneity of 
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enzyme distribution throughout the hepatic lobule 
affects the release rates in proportion to the cell 
damage in the periphery or in the central area of the 
lobule (fig.7). This also shows the different patterns 
with lack of oxygen or glycogen depletion [36]. 
Both connections can be seen either histologically or 
deduced from the sites of action of the injurious 
agents. 
Although at present the mechanisms of enzyme 
release are still unknown, the complexity of condi- 
tions and processes involved is beyond doubt. Subtle 
diagnostic enzymology presupposes some insight into 
this subject. After being released, cellular enzymes 
enter body fluids. Viewed from this aspect, the 
releasing cells can be divided into five groups: cells 
with direct contact o the intravascular space (e.g. 
blood cells), cells with direct contact o the intra- 
vascular and the interstitial space (e.g. spleen cells), 
cells with direct contact o the interstitial space only 
(e.g. muscle cells), cells with direct contact o the 
interstitial and the transcellular space (e.g. renal 
tubular ceils) and finally, cells with direct contact o 
all three compartments (e.g. liver cells, which there- 
fore have been chosen as an example in fig.l). Those 
cellular enzymes which are released into the trans- 
cellular space (urine, bile, intestinal contents, etc.) 
emerging from the cells on the inner and outer sur- 
faces of the body, can be left out from further consid- 
eration because they are lost as regards measurement 
in serum. For the remaining portion, the initial course 
is different but finally they become distributed all 
over the extracellular space. This distribution occurs 
slightly faster from the intravascular to the interstitial 
space, than in the reverse direction via the lymphatic 
vessels. Nevertheless, in both ways distribution is
rapid. It accounts for the first rapid phase of the 
well-known biphasic disappearance of injected 
enzymes (fig.8) [37,38,52,56]. The investigation of 
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enzyme limination from the circulation began early 
with the application of tissue extracts and more or 
less purified enzymes [38,41]. Here the fundamental 
work of Fleisher and Wakim [37,42-44,56] must be 
mentioned. They studied the rates of disappearance 
of transaminases and showed the great difference 
between GPT and GOT, and between the cytosolic 
and the mitochondrial isoenzyme of the latter. 
Additionally they tried to find out about the site of 
the elimination of circulating enzymes by a series of 
considered experiments. However, the question of 
whether enzymes gradually loose their activity, thus 
escaping detection and only simulating disappearance, 
or whether their molecules are in fact removed from 
the circulation, remained open. 
The problem could be solved by the use of radio- 
actively labelled enzymes which would remain trace- 
able after inactivation and even after resumption i to 
cells or excretion. With regard to in rive experiments 
labelling of e-amino groups with [14C]acetate [45,46] 
was found to be more suitable than labelling by 
131iodine [47-51]. Not only is the yield of catalytic- 
ally active enzyme after labelling many times better, 
but, aside from the expected minor alteration of the 
electrophoretic mobility, kinetic and molecular 
properties remain unaltered; further, the stability is 
excellent in vitro as well as in vivo. The latter, 
especially, is an indispensable quality in injection 
experiments [30]. 
Many of the conclusions of Fleisher and Wakim 
and others who worked with unlabelled enzymes 
could be confirmed. In addition, proof was furnished 
that enzymes are eliminated in a catalytically active 
form; after distribution, the catalytic activity and 
the radioactivity of an injected enzyme decrease in 
parallel. This is true in serum as well as in lymph, and 
it demonstrates that elimination takes place from 
both the intravascular nd the interstitial space (fig.9) 
[521. 
The half-lives of cellular enzymes in the circulation 
seem to have molecule-specific and species-specific 
properties. This was shown in animals as well as in 
peracutely ill patients. The half-life of an individual 
enzyme is also independent of sex, age, most disease 
states and its actual evel in the plasma [53]. Recently, 
however, evidence has been reported that very high 
doses of some drugs may have an effect on the half- 
life [54]. 
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Fig.9. Radioactivity and enzyme activity in serum and lymph 
in the dog (Hs4) after i.v. injection of [~4C]LDHs. 
There is no correlation between half-life and 
molecular weight, as can be read from the very differ- 
ent disappearance rates of the LDH-isoenzymes which 
have virtually the same molecular weight (fig.10) 
[54,55]. However, the half-lives may depend, at 
least partially, on the charge of the enzyme molecules. 
Substitution of the side chains of LDH-5 with polar 
groups results in a shorter half-life, whereas ubstitu- 
tion with non-polar groups leaves it unaltered or 
retards elimination. (riga 1) [54,55]. 
The site of t'mal excretion or elimination of 
circulating enzymes has been under investigation and 
discussion for more than 20 years. Former studies 
have shown, that neither the removal of liver or 
spleen nor of the kidneys or the intestinal tract affects 
the elimination rates [38-40,42,56,57]. It was then 
believed that enzyme limination might be a function 
of the reticule-endothelial system on the basis of 
indirect evidence before the era of labelled enzymes 
[37,42,44,58]. With 14C-acetylated LDH it was 
found that not the reticule-endothelial system but 
the parenchymal cells of most tissues are able to 
incorporate circulating enzyme molecules. The rate 
of incorporation was shown to be higher in organs 
with a rapid protein turnover than in organs with a 
less active protein metabolism [52]. 
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Fig. 12 shows the concentration of radioactivity 
in various tissues after injection of labelled LDH-5 as 
compared to its concentration i  the blood and to 
the average body contents. The sequence of contri- 
butory organs is different when the size of the organ 
is accounted for and the respective radioactivities are 
expressed a percentage of the original dose applied 
(fig. 13). It came as a surprise that the cells of the 
reticule-endothelial and the lymphatic system, e.g. 
the Kupffer cells in the liver or the lymphocytes are 
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Fig.13. Radioactivity distribution after 160 rain in organs and 
body fluids in dogs; expressed in percent of injected ose 
(Hs2 and H~). 
not accentuated in autoradiography, but the paren- 
chyma of the organs and among blood cells the 
granular leucocytes only are accentuated [52]. 
A considerable portion of the injected radio- 
activity, but virtually no enzyme activity is found 
in urine and bile within the first 8 hours after injec- 
tion of LDH. It can be concluded from experiments 
in dogs and rats that these findings in urine and bile 
are attributable to non-dialyzable split-products of 
the enzyme molecule after partial degradation i the 
littoral parenchymal cells of urinary and biliary 
tract, which exhibit a considerable accumulation of 
% HALFLIFE 
LDH-I I13"-60 
I 
2 ~ G P T  ~7 "-10 
H I~ y 
5 CPK 15 
6 
7 -t LDH-5 10 *- 2 
J 8 
0.'5 T hour 
Fig. 14. Enzyme limination i human: plasma disappearance 
rates, 
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radioactivity in autoradiographic pictures [52]. Even 
low molecular weight enzymes, e.g. amylase, are 
eliminated from the circulation by the kidneys into 
the urine in the catalytically active form only in small 
proportions. Most enzyme activities in bile and urine, 
originate from the littoral cells themselves and not 
from the plasma [38,39,59-61].  The ideas about 
enzyme elimination are still fragmentary [62]. Never- 
theless, the well-deffmed ifferent half-lives of enzymes 
in the plasma are of major diagnostic siRnificance 
(fig.14) [53]. 
Considering an individual enzyme, the constancy 
of its disappearance rate allows one to assume that 
modifications of its actual evel in the plasma reflect 
only the alterations of inflow. Diagnostic enzymology 
in general is founded on this assumption. Considering 
enzyme patterns in the serum, the different half-lives 
of the respective enzymes contribute a great deal to 
the distortion of the original tissue pattern. 
For the interpretation of enzyme patterns under 
diagnostic aspects the analysis of the distortion is just 
as weighty as e.g. the notion of the tissue patterns, 
the normal values in the serum, or the reliability of 
the methods. The use, which can be made of the 
understanding of the prerequisites and processes 
forming enzyme patterns in the serum is outlined and 
exemplified in fig.15 [35]. 
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Enzyme patterns of 
tissues 
Distribution of 
enzymes in the 
tissues 
IntraceUular locali- 
zation of enzymes 
Alteration of the 
enzyme patterns of 
the organs with 
protracted cellular 
damage 
Application i  serum 
Recognition of the organ of 
origin by organ-specific ratios 
of enzymes 
Recognition of the localization of 
cell damage by the ratios of 
enzymes with different distribu- 
tion in the tissue 
Recognition of the severity of 
single cell damage by the ratios 
between cytosolic and mito- 
chondrial enzymes 
Recognition of the stage of a 
chronic disease by the ratios of 
enzymes with altered activity to 
enzymes with unaltered activity 
in the tissue 
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Fig. 15. Application of pathophysiology to enzyme diagnostics in serum. 
Diagnostic application 
Any diagnostic method is expected to indicate, 
reliably, sensitively and specifically, deviations from 
the normal state at a negligible risk to the patient and 
demanding as little as possible of him. These demands 
are largely met by enzyme determinations in the 
serum. The reliability, sensitivity and specificity of 
the respective methods are fair to excellent, and the 
patients are only minimally inconvenienced. From 
the diagnostic point of view enzyme leakage is in 
itself a very sensitive sign of disorder. The range of 
pathological changes compatible with life is far 
greater than with other clinico-chemical parameters. 
A hundred times normal evels are not uncommon 
and even the thousand-fold has been found (fig. 16). 
Thus, possible gradations between the extremes and 
the normal are unusually free, giving much facility 
to differentiation. 
The diagnostic specificity of the alterations of 
enzyme activities in the serum is, however, much less, 
at least at first sight. Among the enzymes used in 
practice, there are very few organ specific ones and 
no disease-specific ones at all. 
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Fig.l 6. Degree of elevation of cellular enzymes in serum as compared to that of other plasma constituents, exemplified by GOT 
activity vs. 7-globulin concentration in fiver disease. 
The diagnostic specificity can be greatly enhanced 
yet by benefiting from the notions of physiology and 
pathophysiology of enzymes at hand [12,22,63-65] .  
From the enzyme patterns of tissues the 'leading 
enzymes' for the recognition of the affected organ 
can be derived [65].  As can be read from table 3 
scarcely one single enzyme is sufficient, but in many 
cases advantage must be taken from the different 
Table 3 
'Leading enzymes' for organ diagnosis 
Liver and biliary system GPT, GLDH, 7-GT, CHE, (AP) 
Heart CPK, GOT, LDH (Isoenzyme 1) 
Skeletal muscle CPK, ALD, (GOT) 
Bone AP, SP 
Blood LDH 
Pancreas Amylase, Lipase 
Prostate SP (tartrate inhibitable) 
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GOT: ~ 50 U/I 
organ? 
GPT: ~ 20 U./I ~ 100 U/I 
organ? liver/biliary tract 
CI~K: ~ 15 U/1 ~ 250 U/I ~ 1500 U/I 
organ? heart sketeletal muscle 
LDH: ~ 150 U/1 ~ 2509 U!l 
organ? blood cells 
AP: ~ 120 U/I ~ 500 U/I 
organ? bones? liver/biliary tract? 
7-GT ~ 75 U/I ~ 15 U/1 ~ 750 U/1 
liver bones liver/biliary tract 
Fig.17. Enzyme ratios in serum for the diagnosis of the injured organ. 
ratios of more or less unspecific or only group-specific 
enzymes and isoenzymes in the various organ systems. 
Fig. 17 gives an example how to reach organ 
differentiation, proceeding from the assumption that 
the activity of GOT in the serum is only about hree 
times elevated, which is a rather ambiguous value. In 
reality, organ diagnosis is by no means the main object 
of enzyme determinations in the serum; it cannot be, 
because of the limitations of their applicability. They 
are rather useless in diseases of those organs, which are 
not listed on table 3, e.g. diseases of the kidneys, the 
respiratory tract, the endocrine glands, etc. [66-72]. 
In the diseases of these organ systems enzyme altera- 
tions in the serum also occur sometimes. But only the 
secondary affliction of organs, which are accessible 
for diagnostic enzymology in general, are thus mani- 
fested. This is especially true in malignancies: they 
exhibit characteristic enzyme patterns in the serum 
only in the case of metastases in the liver or the 
skeletal system. Even carcinoma of the prostate 
cannot be reliably detected by the estimation of the 
prostatic isoenzyme of acid phosphatase b fore the 
tumor has penetrated the capsule of the gland [73]. 
This is, however, partly due to unsatisfactory assay 
methods. 
As for other small organs, e.g. heart or pancreas, 
only acute cellular damage l ads to distinct elevations 
of enzymes in the serum. This confines the applica- 
tion of enzyme determinations virtually to myocardial 
infarction on the one hand and acute pancreatitis or 
the acute relapses of chronic pancreatitis on the other. 
Among the disorders of the hemopoetic system, it is 
primarily untreated pernicious anemia with its 
extremely high LDH activity, which is a rewarding 
object of enzyme diagnosis in the serum. With the 
diseases of skeletal muscles and bones elevated 
enzyme activities may arouse suspicion of an illness 
or can serve to find carriers of hereditary disorders, 
but they don't contribute much to differential 
diagnosis [66-72]. 
On the other hand, in nearly all diseases mentioned, 
periodical enzyme measurements for the follow-up of 
the course, for the evaluation of desirable and unde- 
sirable effects of treatment, peculiarly of drugs, and 
for the early detection of complications involving 
other organs, can be carried out easily and advantage- 
ously [74]. 
Up to now, diagnostic enzymology flourishes most 
in hepatology. Here, several favorable prerequisites 
coincide: the size of the organ, the absence of a 
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basal membrane around the hepatic sinusoids, and 
the multifarious enzyme quipment of the paren- 
chymal cells. The former two qualities account for 
the sensitivity by which even minute hepatocellular 
damage is indicated by the elevation of cellular 
enzymes of hepatic origin in the serum. Thus enzyme 
determinations are most suitable as screening tests for 
hitherto subclinical hepatic disorders, such as chronic 
inflammations and toxic injuries, be that alcohol or 
industrial poisons or drugs with hepatotoxic side- 
effects. Fig. 18 demonstrates the high incidence of 
abnormal findings with the four 'screening' enzymes 
in chronic inflammatory diseases of the liver [72,75]. 
The rich enzyme quipment of the liver permits 
differential diagnosis to be advanced into considerable 
details. That is why nearly all the examples in fig. 15 
are taken from liver pathology. An adequate set of 
enzymes for differential diagnosis of the disorders of 
the liver and the biliary tract contains ome, whose 
extracellular increase indicates disturbances of cellular 
permeability, (e.g. GOT, GPT, GLDH, LDH,) others, 
whose elevations in the serum indicates not only 
raised permeability, but enhanced synthesis of these 
membrane-bound enzymes [76-82]. This cellular 
reaction is frequently provoked by or combined with 
cholestasis, which can be evaluated by a concomitant 
rise of, for example, 7-GT and AP even in the non- 
jaundiced patient. The third group of enzymes used 
in hepatology comprises CHE and clotting factors 
Chronic hepatitis (all types) n = 154 
GOT GPT 3,-GT 
Normal 
activity: \5% 8%/ 8% 
V 
\ 2% 
V 
0.6% 
CHE 
35% 
/ 
Cirrhosis (all types and stages) 
GOT GPT 
Normal 
activity: \6% 28%/ 
V 
\ 4% 
n = 131 
"r-GT CHE 
12% 11% 
V 
. 
0.7% 
Fig.18. Sensitivity of a small enzyme pattern with chronic 
liver diseases. 
which are synthesized in the liver and secreted into 
the plasma. The decrease of these plasma-specific 
enzymes indicates reduction of the synthesizing and 
secreting capacity or of the number of liver cells or 
of both [64,68,70,72,74]. 
By enzyme determinations in the serum in liver 
disease various functions can thus be examined and 
information as to the extent, the severity, the stage 
and the type of cellular damage can be derived by 
analysing the distortion of the enzyme pattern in the 
serum (see fig.15) [35,83]. 
Clinical experience and comparison with other, 
especially morphological findings have shown charac- 
teristic enzyme patterns to belong to distinct liver 
diseases, their successive stages and their different 
etiology. 
Fig. 19 gives an example for the differential- 
diagnostic procedure starting again with the ambiguous 
GOT activity of about 50 U/1. Although the given 
numbers are schematized and deviation may be 
considerable in individual cases, the diagnostic 
accuracy is as high as 80-90%. This is not worse 
than with other more taxing and more risky 
diagnostic methods. 
Present problems and out look 
After the rapid progress of clinical enzymology 
during the '50s and '60s, recently, a feeling of satura- 
tion and even symptoms of fatigue have been noticed 
in this intermediate field between applied biochemistry 
and medicine. Its achievements can be considered to 
be fairly satisfactory only with hepatology. 
A predominant concern of today's clinical enzymo- 
logists is the improvement of routine and reference 
assay methods and their standardization national 
and international levels. 
A second field of 15resent investigation deals like- 
wise with methodology, but rather with its funda- 
mentals. The principle of determination of enzymes 
by their respective catalytic activities, so dependent 
upon the conditions of assay - though generally 
specific and sensitive nough - might be replaced in 
future by utilizing the antigenic qualities of the 
enzyme proteins for measurement. At present, assays 
of this type are in use either for isoenzyme differentia- 
tion or for enzymatic analysis of other compounds, 
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Fig.19. Enzyme ratios in serum for the diagnosis of the type of liver injury. 
e.g. hormones. Probably, enzyme immunoassays in a 
restricted sense will facilitate or even make possible 
to enlarge the diagnostic set by such enzymes, which 
would give significant information i  disease states, 
but whose activity determinations are too tricky for 
routine. 
The search for further enzymes which might 
complement the enzyme patterns used hitherto - tiny 
in view of the real number of enzymes - constitutes a 
third area of work. Under clinical aspects, only such 
enzymes that are likely to supply new information and 
fill genuine gaps in today's diagnostic possibilities are 
worth investigating. Therefore, success in this field 
presupposes ndeavors in biochemistry, physiology 
and pathophysiology as well. More than the metabolic 
function of an enzyme is taken into consideration, 
the cellular origin, its site of function, its molecular 
forms and, last but not least, its behavior in distinct 
disorders, are the main points of interest. It appears 
that by now the easily accessible nzymes are 
exploited for medicine. The investigation of special 
enzymes, e.g. of the cell surface, of the replication 
apparatus, or of the antibody formation system, will, 
of course, be difficult, but seems promising. There is 
no reason for fatigue or resignation, on the contrary, 
a challenge for co-operation i further developmental 
work. 
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